Apollon
Cambridge
About Apollon
Apollon develops noninvasive continuous glucose monitoring systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.7M
- Funding stage: Seed
- Last round: Grant (Nov 2025)
- Website: apollon.bio
- Phone: 617-201-1467
Industries & Categories
Biotechnology, Diabetes, Health Care, Machine Learning, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/apollon-78112 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.